Status:
COMPLETED
The Differential Effects of 3 Different Immunosuppressive
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Astellas Pharma US, Inc.
Conditions:
Immunosuppression
Kidney Transplantation
Eligibility:
All Genders
18+ years
Brief Summary
The study is a laboratory investigation comparing the regulatory effects of different immunosuppressive therapies in an in vitro human MLR assay of selecting specific immunosuppressive therapy to prom...
Detailed Description
Life-long immunosuppressive (IS) therapy is typically required in the great majority of organ transplants. Immunobiologically correct IS dosing, tapering to low levels and/or monotherapy could lower t...
Eligibility Criteria
Inclusion
- Adults 18 years of Age or Older
- Undergoing living donor renal transplant
Exclusion
- No active infection or history of malignancy
- No HIV infection
- No Hepatitis C (HCV) infection
- No prior transplant (kidney or other organ)
- No chromic use of immunosuppressive therapy or history of autoimmune disease
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00729248
Start Date
July 1 2008
End Date
January 1 2010
Last Update
August 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611